Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Potential Role of Advanced Glycation End-products in the Pathogenesis of Paediatric Allergies

NCT04273152 is registered in ClinicalTrials.gov with Federico II University as lead sponsor.

NCT NCT04273152
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04273152 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Potential Role of Advanced Glycation End-products in the Pathogenesis of Paediatric Allergies
Lead sponsor
Federico II University
Phase
Observational
Overall status
Completed
Start date
January 1, 2018
Completion date
March 30, 2020
Enrollment
200 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergy